Beranda › Diabetes Tipe 1 › New York
Uji klinis Diabetes Tipe 1 di New York
23 studi untuk Diabetes Tipe 1 mencari peserta di lokasi di New York.
Kota di New York
Teks studi resmi (Bahasa Inggris)
App-Based Certified Diabetes Education Therapy (AB-CDE)
- Mount Sinai School of Medicine, New York
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07282639A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- University At Buffalo - Jacobs School Of Medicine- Site Number : 8400006, Buffalo
- Endocrine Associates of West Village- Site Number : 8400064, New York
- Columbia University Irving Medical Center- Site Number : 8400009, New York
Menerima pesertaFase 3
Usia 1 hingga 25 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07088068CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
- UBMD Pediatrics - University of Buffalo, Buffalo
- Hassenfield Children's Hospital, New York
- NYU Langone Diabetes & Endocrine Associates, New York
Menerima pesertaFase 1/2
Usia 12 hingga 35 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06783309Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
- Columbia University, New York
Menerima pesertaFase 2
Usia 4 hingga 34 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07216391Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- Columbia University, New York
Menerima pesertaFase 2
Usia 8 hingga 45 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07142252A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
- University of Buffalo, Buffalo
Menerima pesertaFase 1/2
Usia 9 hingga 20 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07061574Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
- SUNY Upstate Medical Center, Albany
Menerima peserta
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07599982HLA Demographics Study in Adults With Type 1 Diabetes
- Icahn School of Medicine at Mount Sinai, New York
Menerima pesertaStudi observasional
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT06860516Long-Term Outcomes of Teplizumab in Routine Clinical Care
- Investigational Site Number: 8400001, New York
- Investigational Site Number: 8400002, Syosset
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT07360080SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- University at Buffalo MD Physicians Group, Buffalo
Menerima pesertaFase 2
Usia 5 hingga 40 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT07187531APP-MNT: App-Enhanced Medical Nutrition Therapy on Glycemic Outcomes and Quality of Life
- Weill Cornell Medicine, New York
Menerima peserta
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT07773779A Study of GNTI-122 in Adults Recently Diagnosed With T1D
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University, New York
Menerima pesertaFase 1
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT06919354Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
- Circuit Clinical, Buffalo
Menerima pesertaStudi observasional
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 1 Jul 2026 · NCT06144554Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study
- Mount Sinai, New York
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jun 2026 · NCT07676565Kidney Precision Medicine Project
- Mount Sinai, New York
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Apr 2026 · NCT04334707Registry for Stage 2 Type 1 Diabetes
- Women & Children's Hospital of Buffalo- Site Number : 8400018, Buffalo
- Feinstein Institute for Medical Research (Northwell)- Site Number : 8400016, Manhasset
- Ten's Medical PC- Site Number : 8400027, Staten Island
- dan 1 lainnya
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT06481904Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes
- Montefiore Einstein Medical Center, The Bronx
Menerima peserta
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 1 Apr 2026 · NCT06236607Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- SUNY Upstate Medical University, Syracuse
- Albert Einstein College of Medicine / Montefiore Medical Center, The Bronx
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 24 Mar 2026 · NCT06217302Cholesterol Lowering and Residual Risk in Diabetes, Type 1
- New York VA Hospital, New York
- NYC Health + Hospitals/Bellevue, New York
- NYU Langone Health, New York
- dan 1 lainnya
Menerima pesertaFase 4
Usia 18 hingga 89 · Semua jenis kelamin · Diperbarui 29 Des 2025 · NCT05641753Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression
- Albert Einstein College of Medicine, The Bronx
Menerima peserta
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 30 Okt 2025 · NCT05734313TrialNet Pathway to Prevention of T1D
- Columbia University, New York
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 2 hingga 45 · Semua jenis kelamin · Diperbarui 1 Jul 2025 · NCT00097292NYSCF Scientific Discovery Biobank
- New York Stem Cell Foundation Research Institute, New York
Menerima pesertaStudi observasional
30 Days · Semua jenis kelamin · Diperbarui 3 Mar 2025 · NCT06203106PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life
- Mt Sinai, New York
Menerima pesertaStudi observasionalSukarelawan sehat diterima
0 Days – 99 Years · Semua jenis kelamin · Diperbarui 21 Nov 2023 · NCT06141434Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.